<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PONE-D-12-08344</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0040806</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Computational biology</subject>
            <subj-group>
              <subject>Signaling networks</subject>
              <subject>Systems biology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Molecular cell biology</subject>
            <subj-group>
              <subject>Signal transduction</subject>
              <subj-group>
                <subject>Signaling cascades</subject>
                <subj-group>
                  <subject>MAPK signaling cascades</subject>
                </subj-group>
              </subj-group>
              <subj-group>
                <subject>Mechanisms of signal transduction</subject>
                <subject>Signaling pathways</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Theoretical biology</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Mathematics</subject>
          <subj-group>
            <subject>Applied mathematics</subject>
            <subj-group>
              <subject>Complex systems</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Molecular Biology</subject>
          <subject>Computational Biology</subject>
          <subject>Mathematics</subject>
        </subj-group>
      </article-categories><title-group><article-title>Retroactive Signaling in Short Signaling Pathways</article-title><alt-title alt-title-type="running-head">Retroactive Signaling</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Sepulchre</surname>
            <given-names>Jacques-Alexandre</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Merajver</surname>
            <given-names>Sofía D.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Ventura</surname>
            <given-names>Alejandra C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Institut Non Linéaire de Nice, UMR 7335 CNRS - University of Nice Sophia Antipolis, Valbonne, France</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Department of Internal Medicine, and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, United States of America</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Instituto de Fisiología, Biología Molecular y Neurociencias, CONICET and Departamento de Fisiología, Biología Molecular y Celular, Universidad de Buenos Aires, Buenos Aires, Argentina</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Katoh</surname>
            <given-names>Masaru</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">National Cancer Center, Japan</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">jacques-alexandre.sepulchre@inln.cnrs.fr</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: JAS ACV. Performed the experiments: JAS ACV. Analyzed the data: JAS ACV. Wrote the paper: JAS SDM ACV.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <year>2012</year>
      </pub-date><pub-date pub-type="epub">
        <day>26</day>
        <month>7</month>
        <year>2012</year>
      </pub-date><volume>7</volume><issue>7</issue><elocation-id>e40806</elocation-id><history>
        <date date-type="received">
          <day>21</day>
          <month>3</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>6</month>
          <year>2012</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2012</copyright-year><copyright-holder>Sepulchre et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <p>In biochemical signaling pathways without explicit feedback connections, the core signal transduction is usually described as a one-way communication, going from upstream to downstream in a feedforward chain or network of covalent modification cycles. In this paper we explore the possibility of a new type of signaling called retroactive signaling, offered by the recently demonstrated property of retroactivity in signaling cascades. The possibility of retroactive signaling is analysed in the simplest case of the stationary states of a bicyclic cascade of signaling cycles. In this case, we work out the conditions for which variables of the upstream cycle are affected by a change of the total amount of protein in the downstream cycle, or by a variation of the phosphatase deactivating the same protein. Particularly, we predict the characteristic ranges of the downstream protein, or of the downstream phosphatase, for which a retroactive effect can be observed on the upstream cycle variables. Next, we extend the possibility of retroactive signaling in short but nonlinear signaling pathways involving a few covalent modification cycles.</p>
      </abstract><funding-group><funding-statement>ACV is a member of the Carrera del Investigador Científico (CONICET) and was supported by the Department of Defense Breast Cancer Research Program, the Center for Computational Medicine and Bioinformatics (University of Michigan), and the Agencia Nacional de Promoción Científica y Tecnológica (Argentina). SDM receives funding from the Breast Cancer Research Foundation. The international program of scientific collaboration PICS 05922 between CNRS (France) and CONICET (Argentina) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="13"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>One of the most vital processes in biology is the transduction of signals along biochemical pathways, enabling the living cell to elicit appropriate responses to chemical and physical stimuli <xref ref-type="bibr" rid="pone.0040806-Nelson1">[1]</xref>. In this context, the concept of signaling cascade is used as a paradigm or a model of signaling pathways. It consists of a chain of enzymatic reactions wherein a protein is interconverted reversibly between two forms. At each stage in the cascade, the activated form of the protein, which usually is a covalently modified derivative of the native protein, serves as the enzyme to activate the protein in the next stage in the chain and so on. Thus, a signaling cascade consists of a succession of covalent modification cycles, whose classical representative example is the phosphorylation/dephosphorylation cycle, but the general concept is broadly applicable. In some important cases, such as the well-studied MAPK cascades, the stages are in fact composed of double phosphorylations <xref ref-type="bibr" rid="pone.0040806-Seger1">[2]</xref>, <xref ref-type="bibr" rid="pone.0040806-Huang1">[3]</xref>. In all cases, the concept of cascade clearly indicates a notion of flow oriented unidirectionally.</p>
      <p>A general intracellular signaling network may consist of several interconnected cascades <xref ref-type="bibr" rid="pone.0040806-Elion1">[4]</xref>. Its topology can then be described as an oriented graph whose nodes represent stages of the cascades and the arrows serve to relate the activated proteins at a given stage to other covalent modification cycles or to a substrate targeted by the network. Associated with such a graph one may define several signaling pathways, namely several paths in the oriented graph, going from a top vertex, representing a biochemical entry of the system, e.g. a ligand, towards the bottom stage of one of the cascades, e.g. a transcription factor for some genes. A simple type of signal that can be transmitted in this system is a step increase of the enzyme activating the top cycle of one signaling pathway. Several studies have been devoted to the modeling of the propagation of such signal in signaling chains, and on the transmission properties as a function of most of the parameters of the cascade <xref ref-type="bibr" rid="pone.0040806-Huang1">[3]</xref>, <xref ref-type="bibr" rid="pone.0040806-Goldbeter1">[5]</xref>–<xref ref-type="bibr" rid="pone.0040806-Feliu1">[7]</xref>.</p>
      <p>The mathematical modeling of signaling pathways often considers a simplified set of equations in which each cycle is described by a single variable <xref ref-type="bibr" rid="pone.0040806-Goldbeter1">[5]</xref>. In a previous study, we highlighted that these simplified models overlooked the property of retroactivity between two successive stages of the cascades, and we proposed a new type of simplified modeling for cascades to account for this important signaling property <xref ref-type="bibr" rid="pone.0040806-Ventura1">[8]</xref>. The concept of retroactivity means that the response property of a well-characterized input/output isolated device can change dramatically when this device is coupled to a downstream load. In the context of signaling pathways, retroactivity is a phenomenon that arises due to enzyme sequestration in the intermediate complex enzyme-next protein in the cascade. Its main consequence is that a downstream perturbation -e.g. of the protein- can produce a response in a component upstream of the perturbation without the need for explicit feedback connections. In refs. <xref ref-type="bibr" rid="pone.0040806-Ventura1">[8]</xref>, <xref ref-type="bibr" rid="pone.0040806-DelVecchio1">[9]</xref> this effect was described independently by two groups for the first time. The main focus in ref. <xref ref-type="bibr" rid="pone.0040806-Ventura1">[8]</xref> was to derive a simplified description of signaling cascades with one variable per cycle while keeping the retroactive property, after noticing that the standard simplifications on modeling cascades were explicitly avoiding such effects. The study of the effect (referred to as retroactivity in <xref ref-type="bibr" rid="pone.0040806-DelVecchio1">[9]</xref>) was done mostly numerically in <xref ref-type="bibr" rid="pone.0040806-Ventura1">[8]</xref>, introducing the notion of “reverse stimulus response curve”. Now, we study in detail reverse stimulus response curves, by characterizing both analytically and numerically when to expect a measurable upstream effect due to a downstream change in a control parameter. This work provides a roadmap for planning experiments that carefully account for this phenomena.</p>
      <p>The absence of retroactivity for a signaling module implies that the state variables of this module do not change when its output is used as the input of another device. Special conditions are to be met in the design of a network unit in order to minimize the retroactivity <xref ref-type="bibr" rid="pone.0040806-DelVecchio1">[9]</xref>, <xref ref-type="bibr" rid="pone.0040806-Ossareh1">[10]</xref>. In the context of engineering, and specifically in synthetic biology where modularity is required <xref ref-type="bibr" rid="pone.0040806-Andrianantoandro1">[11]</xref>–<xref ref-type="bibr" rid="pone.0040806-Anderson1">[13]</xref>, retroactivity is usually considered as a nuisance, often preventing the proper functioning of devices that consists of assemblies. The property of pathway retroactivity started to gain interest in the systems biology community <xref ref-type="bibr" rid="pone.0040806-DelVecchio1">[9]</xref>, <xref ref-type="bibr" rid="pone.0040806-Hartwell1">[14]</xref>–<xref ref-type="bibr" rid="pone.0040806-Wynn1">[16]</xref>. Retroactivity tends to be attenuated in long signaling cascades <xref ref-type="bibr" rid="pone.0040806-Feliu1">[7]</xref>, <xref ref-type="bibr" rid="pone.0040806-Ossareh1">[10]</xref>. However, ref. <xref ref-type="bibr" rid="pone.0040806-Ossareh1">[10]</xref> also shows that the probability that a 3-stage cascade exhibits retroactivity is around 0.5, so under many commonly encountered conditions, retroactivity occurs. Indeed, recent experiments demonstrate that retroactivity can be set in evidence and measured <italic>in vivo</italic> in the MAPK cascade controlling the early development of drosophila embryos <xref ref-type="bibr" rid="pone.0040806-Kim1">[17]</xref>. An <italic>in vitro</italic> study shows that retroactivity effects can be easily induced at one stage of the signaling system regulating the nitrogen assimilation in <italic>E. coli</italic> <xref ref-type="bibr" rid="pone.0040806-Ventura2">[18]</xref>. In short, retroactivity can be experimentally demonstrated in signaling pathways. In the recent paper by Wynn et al <xref ref-type="bibr" rid="pone.0040806-Wynn1">[16]</xref>, it is shown that an important consequence of retroactivity is its role in the cellular response to a targeted therapy. In particular, we characterized the fact that kinase inhibitors can produce off-target effects as a consequence of retroactivity. In this numerical study, a statistical methodology based on a random sampling of the parameter space was utilized. In particular, that study considered a signaling topology with 3 single cycles, where one of them activates the other two in parallel. This system is also analysed in the present paper which is based on a numerical and analytical study of the nonlinear equations. In that sense, both articles complement each other.</p>
      <p>Moreover, in the present work, we make use of the property of retroactivity in order to extend, theoretically, the standard view of signaling to a new type of intracellular signaling. Indeed, the existence of retroactivity in signaling pathways turns the usually one-way oriented graphs mentioned above, into two-way oriented graphs, with arrows going now from downstream to upstream. We call <italic>retroactive signaling</italic> the design of a pathway that exploits this possibility, that is to say, an extended signaling pathway which comprises a connected path of upstream signaling from output to input (cf. <xref ref-type="fig" rid="pone-0040806-g001">Fig. 1</xref>). Since retroactivity is a secondary effect, when compared with the usual activation in signaling cascades, a retroactive signaling pathway would typically include only one or a few upstream arrows combined with the usual downstream arrows. Nevertheless, the possibility of retroactive steps in a signaling pathway opens up previously unexplored possibilities for signal transduction.</p>
      <fig id="pone-0040806-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0040806.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Motifs of short signaling pathways illustrating the concept of retroactive signaling in (A) a 2-cycle cascade and (B) in a 3-cycle cascade.</title>
          <p>Thick arrows indicate the direction of signaling.</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.g001" xlink:type="simple"/>
      </fig>
      <p>In this paper we explore this concept for the first time in short signaling pathways like the basic case of a 2-cycle cascade and simple extensions of it. The 2-cycle cascade, or the bi-cyclic cascade, is usually described as a motif comprising 2 cycles and a single arrow linking the activated protein of the first onto the second cycle. In this article, retroactive signaling in this system will be dealt with by analysing how a variation of the parameters affecting the downstream cycle, e.g. varying the total protein concentration in this cycle, or its phosphatase, can induce a response in variables of the upstream cycle. The upstream response can be computed numerically and estimated analytically. We will illustrate the theoretical work with examples of retroactive signaling in short multi-cycle pathways.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <sec id="s2a">
        <title>The Main Question</title>
        <p><xref ref-type="fig" rid="pone-0040806-g001">Figure 1</xref> depicts simple motifs of 2-cycle and 3-cycle pathways. The goal is to study the conditions under which a signal, or a perturbation, that modifies the state of a <italic>downstream</italic> cycle, can be transmitted <italic>upstream</italic>, to another cycle in the context of these short pathways. We will focus most of our studies on what happens to the upstream cycle in a 2-cycle system, when control parameters of the downstream cycle are modified, as for instance its total available protein or its total phosphatase.</p>
        <p>The mathematical equations describing these systems are discussed in the Methods section. To summarize our main notations, we name each cycle in a given signaling pathway by an index <italic>i</italic>(<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e001" xlink:type="simple"/></inline-formula>). We take the convention to call cycle 1 the starting cycle of a retroactive signaling scheme, and to increment the number of the other cycles following their position in the signaling network until the last cycle in the pathway has been reached. <xref ref-type="fig" rid="pone-0040806-g001">Figure 1(B)</xref> shows a simple example of retroactive signaling in the pathway 1<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e002" xlink:type="simple"/></inline-formula>2<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e003" xlink:type="simple"/></inline-formula>3 where cycle 2 is an enzyme for both cycles 1 and 3. For notational convenience we will use variable names to denote both a chemical species and its concentration. For instance, the instantaneous state of each cycle is described by the variables <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e004" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e005" xlink:type="simple"/></inline-formula>, denoting respectively the concentrations of the inactivated and of the activated protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e006" xlink:type="simple"/></inline-formula>, whose total amount is denoted by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e007" xlink:type="simple"/></inline-formula>. The enzymatic activations of a given stage of the cascade on the next stages are indicated by vertical top-down arrows on <xref ref-type="fig" rid="pone-0040806-g001">Fig. 1</xref>, except for the activation of the uppermost stage for which the activating enzyme is a parameter, e.g. <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e008" xlink:type="simple"/></inline-formula> denoting the total concentration of the enzyme converting <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e009" xlink:type="simple"/></inline-formula> into <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e010" xlink:type="simple"/></inline-formula>. In all cases, the enzyme deactivating cycle <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e011" xlink:type="simple"/></inline-formula> has a total concentration denoted by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e012" xlink:type="simple"/></inline-formula>.</p>
        <p>In most signaling systems, the activated form of protein <italic>i</italic> corresponds to its phosphorylated form, in which case the converting enzymes are called <italic>kinase</italic> and <italic>phosphatase</italic>, respectively for the phosphorylation and the de-phosphorylation of the protein. Since this situation is the most frequently present in intracellular signaling modules, in what follows we will often name <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e013" xlink:type="simple"/></inline-formula> the kinase and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e014" xlink:type="simple"/></inline-formula> the phosphatase of cycle 2, just for brevity. Moreover, the activating covalent modification will be referred to as phosphorylation. In fact, all the formalism used in this study can equally well apply to other covalent modifications like adenlylation, methylation, GTP-ase modifications.</p>
      </sec>
      <sec id="s2b">
        <title>Varying the Available Protein in a Signaling Cycle</title>
        <p>In order to describe the 2-cycle cascade (cf. <xref ref-type="fig" rid="pone-0040806-g001">Fig. 1(A)</xref>) from the point of view of retroactive signaling, let us start by suppressing the phosphatase in the upstream cycle, i.e. set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e015" xlink:type="simple"/></inline-formula> in cycle 2. Then, cycle 1 behaves like a single signaling cycle with kinase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e016" xlink:type="simple"/></inline-formula> and with phosphatase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e017" xlink:type="simple"/></inline-formula>. Let us analyse what happens to the activated and the non-activated proteins in cycle 1, when the total available amount of this protein, denoted by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e018" xlink:type="simple"/></inline-formula>, is varied between <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e019" xlink:type="simple"/></inline-formula> and an arbitrarily large value. In what follows, we will see that answering this question will provide a way to analyse simple instances of retroactive signaling.</p>
        <p>The intermediate complex <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e020" xlink:type="simple"/></inline-formula> formed by enzyme <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e021" xlink:type="simple"/></inline-formula> and protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e022" xlink:type="simple"/></inline-formula> is a key chemical species in the coupling between cycle 2 and cycle 1. Thus it is relevant to study how <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e023" xlink:type="simple"/></inline-formula> grows when the total protein of cycle 1 is increased from the value <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e024" xlink:type="simple"/></inline-formula>. <xref ref-type="fig" rid="pone-0040806-g002">Figure 2(B)</xref> shows the case where cycle 1 is deactivated (<italic>i.e.</italic> <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e025" xlink:type="simple"/></inline-formula>). Then, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e026" xlink:type="simple"/></inline-formula> first increases proportionally to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e027" xlink:type="simple"/></inline-formula>, and reaches a plateau corresponding to its saturated value, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e028" xlink:type="simple"/></inline-formula>, when <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e029" xlink:type="simple"/></inline-formula>. This saturating behavior suggests the definition of a characteristic range for the variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e030" xlink:type="simple"/></inline-formula>, meaning that above this range a further increase of total protein in cycle 1 has not much effect on the sequestration of protein in cycle 2. For example, we can define the characteristic range for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e031" xlink:type="simple"/></inline-formula> by extrapolating the initially linear growth of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e032" xlink:type="simple"/></inline-formula> as a function of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e033" xlink:type="simple"/></inline-formula> to its asymptotic value <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e034" xlink:type="simple"/></inline-formula>. This is indicated and denoted on <xref ref-type="fig" rid="pone-0040806-g002">Fig. 2</xref> by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e035" xlink:type="simple"/></inline-formula>. This characteristic range of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e036" xlink:type="simple"/></inline-formula> can be analytically calculated as a function of the parameters of cycle 1. The result is:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e037" xlink:type="simple"/><label>(1)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e038" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e039" xlink:type="simple"/></inline-formula> are the maximal reaction rates defined in Eq.(19), and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e040" xlink:type="simple"/></inline-formula> are the Michaelis-Menten coefficients of the cycle 1 (cf. section Methods). The quantity <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e041" xlink:type="simple"/></inline-formula> will be used in the following in order to non-dimensionalize the parameter <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e042" xlink:type="simple"/></inline-formula> by scaling it with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e043" xlink:type="simple"/></inline-formula> whenever <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e044" xlink:type="simple"/></inline-formula> is plotted (e.g. in abscissa).</p>
        <fig id="pone-0040806-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0040806.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Behaviors of cycle 1 as a function of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e045" xlink:type="simple"/></inline-formula>, the total protein in cycle 1.</title>
            <p>The kinase for this cycle is denoted by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e046" xlink:type="simple"/></inline-formula> and the phosphatase by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e047" xlink:type="simple"/></inline-formula>. The abscissa are scaled by the characteristic range <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e048" xlink:type="simple"/></inline-formula>, cf. Eq. (1). A) Two cases are considered for cycle 1, which is said deactivated if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e049" xlink:type="simple"/></inline-formula> and activated if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e050" xlink:type="simple"/></inline-formula>. B-C) Increase of the intermediate complex <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e051" xlink:type="simple"/></inline-formula> when cycle 1 is respectively deactivated or activated. D-E) Variations of activated <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e052" xlink:type="simple"/></inline-formula> and non-activated <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e053" xlink:type="simple"/></inline-formula> proteins in the two cases <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e054" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e055" xlink:type="simple"/></inline-formula>. The graphs were obtained by solving Eqs.(16)-(18) with the following parameters : <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e056" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e057" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e058" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e059" xlink:type="simple"/></inline-formula>; panels (B-D) : <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e060" xlink:type="simple"/></inline-formula>M.; panels (C-E) : <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e061" xlink:type="simple"/></inline-formula>M.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.g002" xlink:type="simple"/>
        </fig>
        <p><xref ref-type="fig" rid="pone-0040806-g002">Figure 2(C)</xref> shows the increase of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e062" xlink:type="simple"/></inline-formula> when cycle 1 is activated (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e063" xlink:type="simple"/></inline-formula>). It can be shown that in this case the maximum amount for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e064" xlink:type="simple"/></inline-formula> is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e065" xlink:type="simple"/></inline-formula>, with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e066" xlink:type="simple"/></inline-formula>, meaning that the sequestration is lower than in the case where cycle 1 is deactivated. Therefore, we will see in the next Section that in order to optimize the retroactivity in a 2-cycle system, the downstream cycle should be deactivated, so that varying <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e067" xlink:type="simple"/></inline-formula> has a larger effect on <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e068" xlink:type="simple"/></inline-formula> and thereby a greater influence on the upstream cycle.</p>
        <p>At the same time, two distinct behaviors are seen for variables (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e069" xlink:type="simple"/></inline-formula>) as a function of total <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e070" xlink:type="simple"/></inline-formula>, according to whether cycle 1 is activated or not (cf. <xref ref-type="fig" rid="pone-0040806-g002">Fig. 2(D-E)</xref>). If cycle 1 is deactivated the asymptotic behavior is a linear increase of variable <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e071" xlink:type="simple"/></inline-formula> while <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e072" xlink:type="simple"/></inline-formula> tends to a constant. If cycle 1 is activated, the converse happens, namely <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e073" xlink:type="simple"/></inline-formula> grows linearly and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e074" xlink:type="simple"/></inline-formula> reaches a constant value. Therefore, increasing the amount of substrate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e075" xlink:type="simple"/></inline-formula> beyond the characteristic range <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e076" xlink:type="simple"/></inline-formula> in the covalent modification cycle 1 tends to an increase of either the activated or of the deactivated protein, but not of both, and the other variable tends to a constant. These latter values can be computed analytically as follows, if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e077" xlink:type="simple"/></inline-formula> (cf. the section Methods):</p>
        <list list-type="bullet">
          <list-item>
            <p>if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e078" xlink:type="simple"/></inline-formula> then <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e079" xlink:type="simple"/><label>(2)</label></disp-formula></p>
          </list-item>
          <list-item>
            <p>if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e080" xlink:type="simple"/></inline-formula> then <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e081" xlink:type="simple"/><label>(3)</label></disp-formula></p>
          </list-item>
        </list>
        <p><xref ref-type="fig" rid="pone-0040806-g002">Figures 2(D-E)</xref> illustrates also that the graphs of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e082" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e083" xlink:type="simple"/></inline-formula> as a function of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e084" xlink:type="simple"/></inline-formula> can be sketched by piecewise linear approximations. In particular, the initial slope of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e085" xlink:type="simple"/></inline-formula> with respect to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e086" xlink:type="simple"/></inline-formula> is found to be <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e087" xlink:type="simple"/></inline-formula>, whereas the initial slope of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e088" xlink:type="simple"/></inline-formula> is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e089" xlink:type="simple"/></inline-formula> (cf. section Methods).</p>
        <p>The results of this section were obtained by assuming absence of phosphatase in cycle 2, so that cycle 1 behaved as an isolated cycle. In the general case of a 2-cycle system, with some phosphatase acting in the upstream cycle (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e090" xlink:type="simple"/></inline-formula>), the obtained results can change, but the modifications are worked out in the Method section. Particularly, one shows that the characteristic range for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e091" xlink:type="simple"/></inline-formula>, which are now denoted by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e092" xlink:type="simple"/></inline-formula>, has a similar expression to the one defined by Eq.(1), but replacing in this equation <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e093" xlink:type="simple"/></inline-formula> by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e094" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e095" xlink:type="simple"/></inline-formula> is the phosphorylated protein in cycle 2, in the limit of vanishing <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e096" xlink:type="simple"/></inline-formula>. Nevertheless, it appears that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e097" xlink:type="simple"/></inline-formula> (Eq.1) is useful as an upper bound of the characteristic range <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e098" xlink:type="simple"/></inline-formula>, whose a lower bound is given by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e099" xlink:type="simple"/></inline-formula>. Regarding the behavior of the cycle when <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e100" xlink:type="simple"/></inline-formula>, Eq.(2) still holds whatever the value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e101" xlink:type="simple"/></inline-formula> is, if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e102" xlink:type="simple"/></inline-formula>. On the other hand, when <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e103" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e104" xlink:type="simple"/></inline-formula>, the limit (3) gives the final value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e105" xlink:type="simple"/></inline-formula> only approximately. The exact asymptotic behavior of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e106" xlink:type="simple"/></inline-formula>, which cannot be formulated as a simple analytical expression, is given in the Method section (cf. Eq.(39)).</p>
      </sec>
      <sec id="s2c">
        <title>Retroactive Signaling in a 2-cycle Cascade</title>
        <p>Having gained insight into how a covalent modification cycle behaves when its total protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e107" xlink:type="simple"/></inline-formula> is varied, we ask how the cycle 2, which is upstream with respect to cycle 1, can be influenced by varying parameters of the downstream cycle. In an experimental setup, the downstream cycle 1 can be characterized by 2 control parameters, namely the total protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e108" xlink:type="simple"/></inline-formula> as seen before, and the amount of phosphatase acting on the deactivation of cycle 1, i.e. <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e109" xlink:type="simple"/></inline-formula>. In this section the considered control parameters of the 2-cycle cascade will be <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e110" xlink:type="simple"/></inline-formula> or <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e111" xlink:type="simple"/></inline-formula>.</p>
        <p>What kind of variables can we measure on the upstream cycle to observe the effect of varying the control parameters of the downstream cycle? One possibility is to measure the fraction of activated (e.g. phosphorylated) protein in cycle 2 <xref ref-type="bibr" rid="pone.0040806-Kim1">[17]</xref>. The latter is defined by:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e112" xlink:type="simple"/><label>(4)</label></disp-formula>Indeed the intermediate complexes <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e113" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e114" xlink:type="simple"/></inline-formula> both contain some fraction of the phosphorylated protein in cycle 2. In particular, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e115" xlink:type="simple"/></inline-formula> represents the fraction of activated protein 2 that is sequestered in cycle 1. Thus this variable embodies the coupling between the two cycles and the source of retroactivity.</p>
        <p><xref ref-type="fig" rid="pone-0040806-g003">Figure 3</xref> shows the variations of the activated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e116" xlink:type="simple"/></inline-formula> as a function of parameters <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e117" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e118" xlink:type="simple"/></inline-formula> under several conditions, depending on cycle 2 is activated or not. As will become clearer in the next sections, the main message of <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3</xref> is that varying the downstream parameters, the retroactivity on the phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e119" xlink:type="simple"/></inline-formula> is significant only when the upstream cycle starts in deactivated state (left column). It is relatively negligible however, when the upstream cycle starts out activated.</p>
        <fig id="pone-0040806-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0040806.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Phosphorylated fraction of protein 2 as a function of 2 control parameters of the downstream cycle 1, namely <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e120" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e121" xlink:type="simple"/></inline-formula>.</title>
            <p>The graphs are obtained by solving Eqs.(16)-(18) with the following parameters : <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e122" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e123" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e124" xlink:type="simple"/></inline-formula>M; On the left figures (B,D,F,H) cycle 2 is assumed deactivated, with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e125" xlink:type="simple"/></inline-formula>M<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e126" xlink:type="simple"/></inline-formula>M. These values are swapped for the right figures (C,E,G,I) where cycle 2 is assumed activated. Panels (B,C,F,G) : cycle 1 is either deactivated (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e127" xlink:type="simple"/></inline-formula>M), or activated (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e128" xlink:type="simple"/></inline-formula>M). On panels (D,E,H,I), phosphatase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e129" xlink:type="simple"/></inline-formula> is varied from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e130" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e131" xlink:type="simple"/></inline-formula> (so that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e132" xlink:type="simple"/></inline-formula> varies from 0 to 2). Panels (D,H) : for the upper curve the total protein 1 is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e133" xlink:type="simple"/></inline-formula>M and for the lower curve <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e134" xlink:type="simple"/></inline-formula>M. Panel (E,I) : for the upper curve the total protein 1 is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e135" xlink:type="simple"/></inline-formula>M and for the lower curve <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e136" xlink:type="simple"/></inline-formula>M.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.g003" xlink:type="simple"/>
        </fig>
        <sec id="s2c1">
          <title>Varying the available protein of the downstream cycle</title>
          <p>Let us consider in detail the effect of varying the total protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e137" xlink:type="simple"/></inline-formula> in cycle 1. In practice, this can be achieved in various ways, e.g. by overexpressing the gene coding for protein 1, or by interfering with this quantity by adding a drug able to inhibit this protein <xref ref-type="bibr" rid="pone.0040806-Wynn1">[16]</xref>, or by sequestration of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e138" xlink:type="simple"/></inline-formula> resulting from modifying its substrates <xref ref-type="bibr" rid="pone.0040806-Kim2">[19]</xref>. Since the retroactive control of cycle 1 on cycle 2 depends crucially on the complex <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e139" xlink:type="simple"/></inline-formula>, the relevant range of variation for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e140" xlink:type="simple"/></inline-formula> can be estimated by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e141" xlink:type="simple"/></inline-formula> given by Eq.(1). Therefore, the graphs presented in <xref ref-type="fig" rid="pone-0040806-g003">Figs. 3(B-C)</xref> show variations of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e142" xlink:type="simple"/></inline-formula> over a range of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e143" xlink:type="simple"/></inline-formula>, which is adequate to capture the significant variations of the activated fraction of protein 2 induced by varying <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e144" xlink:type="simple"/></inline-formula>. <xref ref-type="fig" rid="pone-0040806-g003">Figure 3(B)</xref> shows that when cycle 2 is deactivated, the variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e145" xlink:type="simple"/></inline-formula> can pass from a value close to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e146" xlink:type="simple"/></inline-formula> to a value close to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e147" xlink:type="simple"/></inline-formula>. Moreover the amplitude variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e148" xlink:type="simple"/></inline-formula> is maximum when cycle 1 is deactivated. In the latter case, we have seen in the previous section that the non-activated protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e149" xlink:type="simple"/></inline-formula> grows proportionally to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e150" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pone-0040806-g002">Fig. 2(D)</xref>). This arbitrarily large increase of the substrate of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e151" xlink:type="simple"/></inline-formula> causes the saturation of enzyme 1 for cycle 1 and the complex <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e152" xlink:type="simple"/></inline-formula> increases towards its maximal allowed value <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e153" xlink:type="simple"/></inline-formula> like in <xref ref-type="fig" rid="pone-0040806-g002">Fig. 2(B)</xref>. Therefore, by increasing <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e154" xlink:type="simple"/></inline-formula>, the phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e155" xlink:type="simple"/></inline-formula> tends to its maximal value <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e156" xlink:type="simple"/></inline-formula>; in this case we have a phenomenon of <italic>total sequestration</italic> of protein 2 in cycle 1.</p>
          <p>On the other hand, if cycle 1 is activated and cycle 2 is still deactivated, the results of the previous section show that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e157" xlink:type="simple"/></inline-formula> reaches only a fraction of total protein 2, namely <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e158" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pone-0040806-g002">Fig. 2(C)</xref>). Here we observe a phenomenon of <italic>partial sequestration</italic> of species 2 by cycle 1. Once this partial sequestration has occurred, a further increase of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e159" xlink:type="simple"/></inline-formula> has no longer an effect on the upstream cycle 2. The latter behaves then as a single covalent modification cycle with a reduced amount of protein 2, equal to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e160" xlink:type="simple"/></inline-formula>. Therefore, the fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e161" xlink:type="simple"/></inline-formula> saturates sooner than before and remains inferior to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e162" xlink:type="simple"/></inline-formula>. It is seen on <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(B)</xref> (thin red lines) that a piecewise-linear sketch for the variations of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e163" xlink:type="simple"/></inline-formula> is sufficient to describe the behavior of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e164" xlink:type="simple"/></inline-formula> as a function of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e165" xlink:type="simple"/></inline-formula>.</p>
          <p>Finally, the case where cycle 2 starts out activated is depicted on <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(C)</xref>. In this situation, the phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e166" xlink:type="simple"/></inline-formula> hardly varies whatever the value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e167" xlink:type="simple"/></inline-formula> is, especially if cycle 1 starts out also activated. If it is deactivated, the variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e168" xlink:type="simple"/></inline-formula> is non zero, but very weak. In conclusion, in order to enhance the retroactive control of cycle 1 on cycle 2, that is to get the larger possible increase of the fraction of phosphorylated protein in cycle 2, and this as a function of parameter <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e169" xlink:type="simple"/></inline-formula> of cycle 1, one should start from a situation where both cycles 1 and 2 are deactivated.</p>
        </sec>
        <sec id="s2c2">
          <title>Varying the phosphatase of the downstream cycle</title>
          <p>We turn now to the retroactive effect of varying the phosphatase of the downstream cycle, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e170" xlink:type="simple"/></inline-formula>, on the fraction of phosphorylated protein in cycle 2. Here the total protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e171" xlink:type="simple"/></inline-formula> is fixed. <xref ref-type="fig" rid="pone-0040806-g003">Figures 3(D-E)</xref> show the variation of the phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e172" xlink:type="simple"/></inline-formula> as a function of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e173" xlink:type="simple"/></inline-formula>, that is a non-dimensionalized parameter proportional to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e174" xlink:type="simple"/></inline-formula> (Eq.(19)). In the same manner as before, one observes that the phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e175" xlink:type="simple"/></inline-formula> exhibits a significative variation only in the case where cycle 2 is deactivated (<xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(D)</xref>). Moreover, the variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e176" xlink:type="simple"/></inline-formula> is seen only when the control parameter <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e177" xlink:type="simple"/></inline-formula> varies in the interval <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e178" xlink:type="simple"/></inline-formula>, that is when cycle 1 passes from its activated to its deactivated state. Then, the level of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e179" xlink:type="simple"/></inline-formula> increases proportionally to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e180" xlink:type="simple"/></inline-formula>, until reaching a plateau depending on the chosen amount of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e181" xlink:type="simple"/></inline-formula>. This plateau, that is the maximum fraction of upstream protein 2 that can be phosphorylated by increasing the phosphatase of the downstream cycle, can be predicted by the expression:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e182" xlink:type="simple"/><label>(5)</label></disp-formula>This equation is derived below, in the section Methods. In this equation, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e183" xlink:type="simple"/></inline-formula> is the maximum free protein 2 that is activated in the limit of arbitrarily large phosphatase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e184" xlink:type="simple"/></inline-formula>. Thus it is unknown a priori but, as a first approximation, it can be replaced by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e185" xlink:type="simple"/></inline-formula> (the value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e186" xlink:type="simple"/></inline-formula> in absence of cycle 1). To get a better estimate, the actual value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e187" xlink:type="simple"/></inline-formula> can be found by using an iterative process.</p>
          <p>Equation (5) allows us to estimate the level of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e188" xlink:type="simple"/></inline-formula> necessary to reach a given fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e189" xlink:type="simple"/></inline-formula> in the limit of large phosphatase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e190" xlink:type="simple"/></inline-formula>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e191" xlink:type="simple"/><label>(6)</label></disp-formula></p>
          <p>In summary, in a 2-cycle cascade, in order to create conditions that may substantially modify the fraction of the activated protein in the upstream cycle by perturbing the parameters of the downstream cycle, it is recommended to deactivate the upstream cycle 2. Then, if the downstream cycle 1 is also maintained deactivated a substantial change in <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e192" xlink:type="simple"/></inline-formula> can be obtained by varying the total protein in the downstream cycle, within a range <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e193" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e194" xlink:type="simple"/></inline-formula> can be computed as a function of the system parameters (Eq.(1)). In the case where the downstream cycle is activated, it is also possible to change <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e195" xlink:type="simple"/></inline-formula> by varying the total protein, but in a smaller range than before, namely <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e196" xlink:type="simple"/></inline-formula>. Varying the phosphatase of the downstream cycle will not modify <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e197" xlink:type="simple"/></inline-formula>, if cycles 1 and 2 are both deactivated. If, on the other hand, the downstream cycle is activated, then a retroactive signaling in <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e198" xlink:type="simple"/></inline-formula> can be achieved by modifying the downstream phosphatase, provided that the total protein 1 is sufficiently abundant (cf. Eq.(6)).</p>
          <p>The above analysis focussed on the changes of the fraction of phosphorylated protein in cycle 2 because the variable <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e199" xlink:type="simple"/></inline-formula> is experimentally accessible. However, it is also interesting to describe the behaviors of the 2-cycle cascade in terms of the free proteins in cycle 2, respectively <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e200" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e201" xlink:type="simple"/></inline-formula>, as will be covered in the next section. Indeed, as discussed below, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e202" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e203" xlink:type="simple"/></inline-formula> are responsible for the possible crosstalk effects in cascades with more than 2 cycles.</p>
        </sec>
        <sec id="s2c3">
          <title>Downregulation of the free proteins in the upstream cycle</title>
          <p>When the upstream cycle 2 is deactivated, <xref ref-type="fig" rid="pone-0040806-g003">Figs. 3(B,D)</xref> demonstrate that the phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e204" xlink:type="simple"/></inline-formula> can be raised by increasing <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e205" xlink:type="simple"/></inline-formula> or <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e206" xlink:type="simple"/></inline-formula> from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e207" xlink:type="simple"/></inline-formula>. How does this growth affect the amount of free non-active and active proteins in the upstream cycle? It is seen on <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(F)</xref> and (H) that the growth of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e208" xlink:type="simple"/></inline-formula> coincides with a decrease of the non-active protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e209" xlink:type="simple"/></inline-formula>. Conversely, the variation of the free activated protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e210" xlink:type="simple"/></inline-formula> is negligible (not shown). Moreover, if cycle 1 is deactivated, addition of the substrate <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e211" xlink:type="simple"/></inline-formula> in cycle 1 can lead to a complete depletion of protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e212" xlink:type="simple"/></inline-formula> in the upstream cycle. The decrease of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e213" xlink:type="simple"/></inline-formula> is roughly linear in the range <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e214" xlink:type="simple"/></inline-formula>, and then beyond this range it is inversely proportional, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e215" xlink:type="simple"/></inline-formula>. When the downstream cycle is activated, the decrease of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e216" xlink:type="simple"/></inline-formula> occurs on the smaller range <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e217" xlink:type="simple"/></inline-formula> and then reaches a plateau that can be analytically predicted (cf. thin continuous lines on <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3</xref>)(F)). This situation reflects the phenomenon of partial sequestration of protein of cycle 2 in the dynamics of cycle 1.</p>
          <p>As illustrated on <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(H)</xref>, the variation of phosphatase in the downstream cycle can also retroactively affects the amount of non-activated protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e218" xlink:type="simple"/></inline-formula>, provided that cycle 1 is activated and that the quantity <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e219" xlink:type="simple"/></inline-formula> is large enough. This figure also shows that the variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e220" xlink:type="simple"/></inline-formula> is well approximated by a linear decrease as a function of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e221" xlink:type="simple"/></inline-formula> or, equivalently, of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e222" xlink:type="simple"/></inline-formula>.</p>
          <p>When the upstream cycle 2 is activated, <xref ref-type="fig" rid="pone-0040806-g003">Figs. 3(C,E)</xref> showed that a variation of control parameters in cycle 1 entailed only minor changes in the fraction of phosphorylated protein in the upstream cycle 2. This result might convey the idea that when cycle 2 is activated no retroactivity can be observed on cycle 2. In reality, this view would be wrong, because in this case there can exist a large decrease of the free active enzyme <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e223" xlink:type="simple"/></inline-formula>, as illustrated on <xref ref-type="fig" rid="pone-0040806-g003">Figs. 3(G,I)</xref>. Indeed, although the fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e224" xlink:type="simple"/></inline-formula> stayed relatively constant on <xref ref-type="fig" rid="pone-0040806-g003">Figs. 3(C,E)</xref>, these graphs showed also that the amount of protein 2 sequestrated by cycle 1 increased under a boost of the control parameters <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e225" xlink:type="simple"/></inline-formula> or <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e226" xlink:type="simple"/></inline-formula>. In fact, the growth of the intermediate complex <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e227" xlink:type="simple"/></inline-formula> is compensated by a corresponding decrease in <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e228" xlink:type="simple"/></inline-formula>, keeping a roughly constant total phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e229" xlink:type="simple"/></inline-formula>. As before, to get a large variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e230" xlink:type="simple"/></inline-formula> by making available more protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e231" xlink:type="simple"/></inline-formula>, cycle 1 should be deactivated, leading to the phenomenon of total sequestration in a range of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e232" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(G)</xref>). In contrast, if the control parameter is the phosphatase of the downstream cycle, then a retroactive response on cycle 2 is possible if the downstream cycle starts activated, while <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e233" xlink:type="simple"/></inline-formula> is large enough (cf. <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(I)</xref>).</p>
        </sec>
      </sec>
      <sec id="s2d">
        <title>Retroactive Signaling in Multi-cycle Pathways</title>
        <p>The results obtained with a 2-cycle cascade can predict the effect of retroactivity in short signaling pathways with more than 2 cycles. We first consider a 3-cycle pathway where the activated protein in the cycle at the top of the pathway is an enzyme that activates two other cycles which are not directly linked together (<xref ref-type="fig" rid="pone-0040806-g004">Fig. 4(A)</xref>-(B)). In the last section we have demonstrated that a change in the parameters of a downstream cycle, for example the amount of phosphatase or the available protein of the cycle 1, can affect the state of the upstream cycle 2. More precisely, we anticipate that when the phosphatase is increased in cycle 1, it can augment the deactivated form of the protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e234" xlink:type="simple"/></inline-formula>. The latter then can bind to a greater amount of enzyme <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e235" xlink:type="simple"/></inline-formula>, which become less available for the activation of other substrates such as the protein in cycle 3. Therefore, to implement the scheme of retroactive signaling 1<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e236" xlink:type="simple"/></inline-formula>2<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e237" xlink:type="simple"/></inline-formula>3, we start by assuming that the upstream cycle 2 is activated and we consider a signal having the form of an increase in the phosphatase of the downstream cycle 1. We know from the above results (cf. <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3</xref>)(I)) that to create a substantial variation in the upstream cycle 2, the phosphatase signal should switch the cycle 1 from an activated state to a deactivated state, considering at the same time a relatively large amount of available protein in cycle 1 (cf. Eq.(6)). Then <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(I)</xref> showed that the switching of the downstream cycle caused a complete decrease of the free phosphorylated enzyme <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e238" xlink:type="simple"/></inline-formula> in the upstream cycle 2. This behavior of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e239" xlink:type="simple"/></inline-formula> can be considered as an output response of the pathway 1<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e240" xlink:type="simple"/></inline-formula>2 that can be used as the input of the conventional signaling pathway 2<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e241" xlink:type="simple"/></inline-formula>3. Therefore a retroactive signaling in the 3-cycle pathway 1<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e242" xlink:type="simple"/></inline-formula>2<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e243" xlink:type="simple"/></inline-formula>3 shown on <xref ref-type="fig" rid="pone-0040806-g004">Fig. 4</xref> is promoted when there is a strong retroactivity on the segment 2<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e244" xlink:type="simple"/></inline-formula>1, but a weak retroactivity on the segment 2<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e245" xlink:type="simple"/></inline-formula>3 with respect to the considered input. Another condition is that, when the downstream cycle 1 is completely activated (i.e. when the phosphatase signal on cycle 1 is absent), cycle 3 should be activated by cycle 2. In this case only, it will feel the strong decay of the free phosphorylated enzyme in the upstream cycle 2 caused by its sequestration in the compounds of cycle 1. <xref ref-type="fig" rid="pone-0040806-g004">Figure 4(A)</xref> illustrates this type of signaling. One sees that cycle 3 can be switched on or off by varying the phosphatase regulating the input cycle 1.</p>
        <fig id="pone-0040806-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0040806.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Retroactive signaling in multi-cycle pathways.</title>
            <p><inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e246" xlink:type="simple"/></inline-formula>M for all <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e247" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e248" xlink:type="simple"/></inline-formula>, except for (A)–(C) <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e249" xlink:type="simple"/></inline-formula>M, and for (D) <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e250" xlink:type="simple"/></inline-formula>M. (A) <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e251" xlink:type="simple"/></inline-formula> is varied in the range [<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e252" xlink:type="simple"/></inline-formula>M] such that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e253" xlink:type="simple"/></inline-formula> goes from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e254" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e255" xlink:type="simple"/></inline-formula>. <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e256" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e257" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e258" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e259" xlink:type="simple"/></inline-formula>M<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e260" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e261" xlink:type="simple"/></inline-formula>M. (B) same but <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e262" xlink:type="simple"/></inline-formula> is varied on the range <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e263" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e264" xlink:type="simple"/></inline-formula>M. (C) identical to (A) except that cycle 2 is deactivated, with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e265" xlink:type="simple"/></inline-formula>M<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e266" xlink:type="simple"/></inline-formula>M. (D) <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e267" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e268" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e269" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e270" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e271" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e272" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e273" xlink:type="simple"/></inline-formula>M<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e274" xlink:type="simple"/></inline-formula>M, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e275" xlink:type="simple"/></inline-formula>M<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e276" xlink:type="simple"/></inline-formula>M.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.g004" xlink:type="simple"/>
        </fig>
        <p>A similar retroactive signaling in the same 3-cycle pathway can be achieved by modifying not the phosphatase but the available protein in the starting cycle 1. Keeping the same parameters as above, <xref ref-type="fig" rid="pone-0040806-g004">Fig. 4(B)</xref> shows that increasing the signaling protein 1 from a low value to four times the characteristic range <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e277" xlink:type="simple"/></inline-formula> entails a deactivation cycle 3. This happens because of the retroactive mechanism between cycles 1 and 2, as discussed in the previous section (cf. <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3</xref>)(G)). In the latter case, the increase of the total protein available in the downstream cycle 1 downregulated the activated enzyme in the upstream cycle 2, assuming that the downstream cycle was deactivated. Here again, by combining a large retroactivity between cycles 1 and 2, but a low one between cycle 2 and 3, one achieves a retroactive signaling between cycle 1 and 3.</p>
        <p>In some covalent modification cycles, the deactivated protein can serve also as an enzyme for another protein modification <xref ref-type="bibr" rid="pone.0040806-Ventura2">[18]</xref>, <xref ref-type="bibr" rid="pone.0040806-Goldbeter2">[20]</xref>. For example a variation of the motif shown on <xref ref-type="fig" rid="pone-0040806-g004">Fig. 4(A)</xref> is a 3-cycle network consisting of one upstream cycle and 2 downstream cycles activated respectively by the phosphorylated and non-phosphorylated forms of protein in the upstream cycle. Then we checked that a change in the phosphatase of one downstream cycle can produce a transition in the other downstream cycle activated by the non-phosphorylated protein in the upstream cycle (not shown).</p>
        <p>To extend the possibility of retroactive signaling to more complex situations than a 3-cycle pathways we now consider a motif of a 5-cycle network in which the activated protein in the top cycle acts as the enzyme regulating two 2-cycle cascades, as shown on <xref ref-type="fig" rid="pone-0040806-g004">Fig. 4(C)</xref>. Can we produce in this case an example of retroactive signaling from one bottom cycle to the other bottom one, numbered respectively by 1 and 5, initiated for instance by a phosphatase variation in cycle 1? Here, the study of the 2-cycle and the 3-cycle systems reported above can also help to answer this question. In this 5-cycle pathway, the subnetwork formed by cycles 2-3-4 has the same topology than the 3-cycle pathway discussed previously. Therefore, since this latter subsystem is suitable for retroactive signaling, let us consider the subnetwork 2-3-4 with the same parameters as considered for the 3-cycle network of <xref ref-type="fig" rid="pone-0040806-g004">Fig. 4(B)</xref>. Then we can link to this system the cycle 1 downstream to cycle 2, and the cycle 5 downstream to cycle 4. For recall, cycle 2 is deactivated. Now we use the result shown on <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(H)</xref>, showing that increasing the phosphatase in cycle 1 is going to reduce the available protein in cycle 2 in such a way that the free activated enzyme in cycle 3 is strongly reduced. This, in turn, deactivates cycle 4, and then cycle 5 as for standard cascades. This example of retroactive signaling scenario is seen on <xref ref-type="fig" rid="pone-0040806-g004">Fig. 4(C)</xref> where the increase in the phosphatase in cycle 1 entails not only the deactivation of cycle 1 (not shown) but also the deactivation of the remote cycle 5. Let us remark that this crosstalk effect can propagate to possible downstream effectors activated by cycle 5.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <p>Cell signaling is generally thought in terms of a series of reversible biochemical reactions that are chained together in a feedforward network where extra connections, called feedbacks, could regulate the information flow from bottom-up. In particular the expression “signaling cascade” was coined to suggest the idea of an upstream to downstream signal transmission. In the simplest scheme of a cascade of two covalent modification cycles, the input signal typically is a steep increase of the enzyme modifying the first protein. Then the latter acts as the enzyme activating the second protein whose concentration is interpreted as the output of this system. In this paper, however, we show that in such a cascade a retroactive signaling is also possible, i.e. transmitting an input signal from downstream to upstream, and we predict conditions for which this phenomenon can be observed. The input signal is now a variation of a biochemical species that can change the state of the downstream cycle. Two cases are considered, namely a change of the total amount of the downstream signaling protein, or a variation of the phosphatase deactivating the same protein. In both cases we work out characteristic ranges of the concentrations of the species for which a retroactive effect can be observed in the upstream cycle. Moreover we show that this potentiality can help to perform retroactive signaling in short multi-cycle pathways.</p>
      <p>A covalent modification cycle is generally described as a two-state entity for which the total level of protein is fixed. However, like all the molecules inside the cell, this signaling protein is subjected to a turnover governed by several processes, including synthesis and degradation <xref ref-type="bibr" rid="pone.0040806-Callis1">[21]</xref>. The changes in these processes alters the total level of proteins. For example the degradation of several signaling proteins is actively regulated by proteases, which has consequences on the signaling dynamics <xref ref-type="bibr" rid="pone.0040806-Soyer1">[22]</xref>. The present study shows that the variation of the total amount of available protein in a downstream signaling cycle can also affect the states of signaling modules upstream in the transduction cascade.</p>
      <p>There are several ways to modify the available protein in the downstream cycle in a cascade of covalent modifications. One way is to change the amount of substrates to which the activated protein of the downstream cycle can bind. For example, in a recent study reported in <xref ref-type="bibr" rid="pone.0040806-Kim1">[17]</xref>, the authors perform experiments on the ERK/MAPK pathway associated with the syncytium state of the <italic>Drosophila</italic> embryo. They manage to modify the amount of substrates of the doubly phosphorylated form of ERK by constructing mutants missing the corresponding substrates. Another way to alter the available protein in the downstream cycle is to add in the medium a kinase inhibitor that can bind to the activated enzyme at the end stage of the pathway <xref ref-type="bibr" rid="pone.0040806-Wynn1">[16]</xref>, <xref ref-type="bibr" rid="pone.0040806-Kumar1">[23]</xref>. Both ways can be modeled by considering an additional chemical reaction of the form:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e278" xlink:type="simple"/><label>(7)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e279" xlink:type="simple"/></inline-formula> represents a substrate or a kinase inhibitor of the downstream protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e280" xlink:type="simple"/></inline-formula>. Then it can be shown that the set of stationary state equations of the signaling pathway is affected only in the conservation equation for the total protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e281" xlink:type="simple"/></inline-formula>. More precisely this latter quantity is replaced by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e282" xlink:type="simple"/></inline-formula>, where 2 additional parameters characterize respectively the total amount <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e283" xlink:type="simple"/></inline-formula> of binding chemical species and the dissociation constant <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e284" xlink:type="simple"/></inline-formula>. Thus, the effect of varying <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e285" xlink:type="simple"/></inline-formula> is qualitatively analog to changing the amount of available protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e286" xlink:type="simple"/></inline-formula>. In particular, when the affinity of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e287" xlink:type="simple"/></inline-formula> for protein 1 is high (i.e., <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e288" xlink:type="simple"/></inline-formula> small), the available downstream protein is approximately reduced by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e289" xlink:type="simple"/></inline-formula>. Therefore under this hypothesis the upstream response in a 2-cycle cascade to a variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e290" xlink:type="simple"/></inline-formula> can straightforwardly be inferred from the curves shown on <xref ref-type="fig" rid="pone-0040806-g003">Figs. 3</xref>. For instance, from <xref ref-type="fig" rid="pone-0040806-g003">Fig. 3(B)</xref> one predicts that in a 2-stage cascade increasing <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e291" xlink:type="simple"/></inline-formula> can decrease the phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e292" xlink:type="simple"/></inline-formula> of the upstream protein, especially if the upstream cycle is in a deactivated state. This phenomenon may be the source of undesirable off-target effects in targeted therapies based on kinase inhibitors <xref ref-type="bibr" rid="pone.0040806-Wynn1">[16]</xref>.</p>
      <p>In Ossareh et al, the authors performed mathematical analysis of retroactivity in a signaling cascade with an arbitrary number of stages. They achieved necessary and sufficient conditions for which retroactivity exists in such chains. Their analysis is based on the linearization of the steady state equations in order to predict how a small downstream perturbation is amplified in the upstream response of an arbitrarily long signaling chain. Those results are complementary to the ones presented in the present paper, in the sense that here we consider short signaling pathways but our analysis is based on the resolution of the full nonlinear equations, and not only on the linearized system. So, it is concerned with arbitrarily large perturbations of the parameters. In fact we show that retroactive signaling is meant to work only for a characteristic range of parameter variations that we analytically estimate by working on the asymptotic behaviors of the system for small and large parameter perturbations.</p>
      <p>Signaling pathways are regulated by several mechanisms, like positive or negative feedback loops linking the output of the cascades and some upstream stages. This requires the existence of specific chemical interactions between the output protein of the cascade and the upstream proteins that are involved in the feedback loop. Our study shows that the property of retroactive signaling can be another way to regulate the functioning of signaling cascades in branched pathways, without explicit feedbacks. In fact, we can further speculate that in natural signaling pathways with possibly several branches, some of the latter would be sensitive to retroactivity and be devoted to the regulation of the usual branches, where signals go in the top-down direction. These results prompt new experiments concerning signaling cascades and possibly new ways to interpret previous results.</p>
    </sec>
    <sec id="s4" sec-type="methods">
      <title>Methods</title>
      <p>Our theoretical study is performed in the framework of coupled nonlinear equations describing the rate of changes of protein concentrations in signaling cascades formed of covalent modification cycles. The model equations are deterministic and based on the law of mass action. Only stationary states of these equations are analysed and thus the mathematical method amounts to solving sets of algebraic nonlinear equations. Thus the issue of how the biochemical species reach the equilibrium is not discussed here, as it has been addressed in some previous studies <xref ref-type="bibr" rid="pone.0040806-Ventura1">[8]</xref>, <xref ref-type="bibr" rid="pone.0040806-DelVecchio1">[9]</xref>, <xref ref-type="bibr" rid="pone.0040806-Jiang1">[24]</xref>. In this respect our analysis is independent of questions related to possible time-scale differences between the kinetics of enzyme/substrate. For example, the usual quasi-steady state approximations are not to be considered since all the variables are at equilibrium.</p>
      <p>Let us note that we assume that the studied signaling pathways possess a stable equilibrium. Although in this paper we will not explicitly discuss the generality of this assumption by performing the linear stability analysis of the equation set, the hypothesis of a stable equilibrium is consistent with the current knowledge. In the literature, published results indicate that non steady behaviors (e.g. sustained oscillations) can arise in signaling cascades only with the concomitant occurence of bistability in the signaling modules <xref ref-type="bibr" rid="pone.0040806-Qiao1">[6]</xref>, <xref ref-type="bibr" rid="pone.0040806-Zumsande1">[25]</xref>. However, this situation was only met with signaling modules described by double-phosphorylations cycles, like in the MAPK cascade. Here the considered signaling pathways do not include double-phosphorylation. Therefore this paper will not consider retroactive signaling in oscillating systems.</p>
      <sec id="s4a">
        <title>Steady States in Basic Models of Signaling Cascades</title>
        <p>Let us introduce the notations used for writing the equations in the case of the simple 2-cycle cascade as depicted on <xref ref-type="fig" rid="pone-0040806-g001">Fig. 1(A)</xref>. Assuming that this system is isolated from other biochemical reactions, the chemical equations describing the transformations of these species can be written as follows:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e293" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e294" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e295" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e296" xlink:type="simple"/><label>(8)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e297" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e298" xlink:type="simple"/></inline-formula> denote enzyme concentrations, whereas <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e299" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e300" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e301" xlink:type="simple"/></inline-formula>) are intermediate enzyme-substrate complexes. These chemical equations readily generalize to the other motifs, e.g. the one shown on <xref ref-type="fig" rid="pone-0040806-g001">Fig. 1(B)</xref>. The kinetic equations of the state variables of the cascades are written using the law of mass actions.</p>
        <p><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e302" xlink:type="simple"/><label>(9)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e303" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e304" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e305" xlink:type="simple"/><label>(10)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e306" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e307" xlink:type="simple"/></disp-formula>with the conservation laws for the total proteins <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e308" xlink:type="simple"/></inline-formula> and total enzyme concentrations <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e309" xlink:type="simple"/></inline-formula>:</p>
        <p><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e310" xlink:type="simple"/><label>(11)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e311" xlink:type="simple"/><label>(12)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e312" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e313" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e314" xlink:type="simple"/></disp-formula>Since we focus only on the stationary states of the system, the time-derivatives of the concentrations can be equaled to zero. This enables to express the variables <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e315" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e316" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e317" xlink:type="simple"/></inline-formula>) in terms of the protein concentrations as follows:</p>
        <p><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e318" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e319" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e320" xlink:type="simple"/><label>(13)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e321" xlink:type="simple"/><label>(14)</label></disp-formula>with the coefficients <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e322" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e323" xlink:type="simple"/></inline-formula>) defined as a function of he kinetic parameters <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e324" xlink:type="simple"/></inline-formula>. One thus recognizes the usual Michaelis-Menten form for the substrate-enzyme complexes. The substitution of these expressions in Eqs.(9)–(10) and in the conservation laws given Eqs.(11)–(12) leads finally to 4 algebraic equations in the unknowns <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e325" xlink:type="simple"/></inline-formula>. Therefore a reduced set of equations (9–14) can be written as:</p>
        <p>
          <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e326" xlink:type="simple"/><label>(15)</label></disp-formula>
          <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e327" xlink:type="simple"/><label>(16)</label></disp-formula>
          <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e328" xlink:type="simple"/><label>(17)</label></disp-formula>
          <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e329" xlink:type="simple"/><label>(18)</label></disp-formula>
        </p>
        <p>A 2-cycle cascade involves 4 enzymatic reactions. Each of those can be characterized also by their maximum reaction rates (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e330" xlink:type="simple"/></inline-formula>). We denote the latter as follows:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e331" xlink:type="simple"/><label>(19)</label></disp-formula>The upper bound of the velocity <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e332" xlink:type="simple"/></inline-formula>, which describes the activation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e333" xlink:type="simple"/></inline-formula>, will depend on the total protein in cycle 2. In the following section we will seek the conditions under which the variations of parameters of cycle 1 produce a significant effect in cycle 2 due to retroactivity. As will be discussed, this property will depend on the states of the variables of both, upstream and downstream cycles. We will use the following terminology: cycle <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e334" xlink:type="simple"/></inline-formula> is said to be <italic>activated</italic> if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e335" xlink:type="simple"/></inline-formula>. Otherwise, it is said to be <italic>deactivated</italic>. This property is easily related to the ratio <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e336" xlink:type="simple"/></inline-formula> in the symmetric case <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e337" xlink:type="simple"/></inline-formula>. Then cycle <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e338" xlink:type="simple"/></inline-formula> is activated if and only if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e339" xlink:type="simple"/></inline-formula> <xref ref-type="bibr" rid="pone.0040806-Goldbeter1">[5]</xref>.</p>
        <p>The following sections give details on the derivation of equations (1)–(3) and (5) used in the section Results.</p>
      </sec>
      <sec id="s4b">
        <title>Variation of the Total Downstream Protein in a 2-cycle Cascade</title>
        <p>Let us consider a 2-cycle cascade as drawn on <xref ref-type="fig" rid="pone-0040806-g002">Fig. 2(A)</xref>, with total upstream protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e340" xlink:type="simple"/></inline-formula>, total downstream protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e341" xlink:type="simple"/></inline-formula>, and total deactivating enzyme <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e342" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e343" xlink:type="simple"/></inline-formula>, respectively for the upstream and downstream cycles. We wish to determine a suitable value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e344" xlink:type="simple"/></inline-formula> that can be used as a characteristic dose of downstream protein inducing a retroactive effect on the upstream cycle. The steady state of this system is given by the solution of Eqs.(15)–(18). As motivated above, we focus on the behavior of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e345" xlink:type="simple"/></inline-formula>, i.e. the intermediate substrate-kinase complex, which at equilibrium is given by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e346" xlink:type="simple"/></inline-formula>. The change of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e347" xlink:type="simple"/></inline-formula> as a function of the total protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e348" xlink:type="simple"/></inline-formula> is illustrated on <xref ref-type="fig" rid="pone-0040806-g002">Fig. 2(B)</xref>–(C) in the case where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e349" xlink:type="simple"/></inline-formula>, but the behavior is the same if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e350" xlink:type="simple"/></inline-formula>. It can be sketched by an increase of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e351" xlink:type="simple"/></inline-formula> proportional to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e352" xlink:type="simple"/></inline-formula> followed by a saturation to a constant value, that is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e353" xlink:type="simple"/></inline-formula> when cycle 1 is deactivated (i.e. <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e354" xlink:type="simple"/></inline-formula>). Therefore the quantity<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e355" xlink:type="simple"/><label>(20)</label></disp-formula>defines a proper characteristic range of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e356" xlink:type="simple"/></inline-formula> for the variation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e357" xlink:type="simple"/></inline-formula>. The upper index of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e358" xlink:type="simple"/></inline-formula> reminds that the result of the right-hand side of this equality depends on the value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e359" xlink:type="simple"/></inline-formula>. In particular, we will be interested to the case <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e360" xlink:type="simple"/></inline-formula> which corresponds to the situation of the isolated signaling cycle 1 with kinase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e361" xlink:type="simple"/></inline-formula> and with phosphatase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e362" xlink:type="simple"/></inline-formula>. To simplify the notations, we will denote in the following:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e363" xlink:type="simple"/><label>(21)</label></disp-formula>and we will show that Eq.(1) holds with this definition. Since <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e364" xlink:type="simple"/></inline-formula>, one deduces that</p>
        <p><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e365" xlink:type="simple"/><label>(22)</label></disp-formula>Now, it suffices to compute the derivative of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e366" xlink:type="simple"/></inline-formula> w.r.t. <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e367" xlink:type="simple"/></inline-formula> and evaluate it at <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e368" xlink:type="simple"/></inline-formula>. This can be analytically performed by differenciating each equation of the system (15)–(18) with respect to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e369" xlink:type="simple"/></inline-formula>. This calculation provides a system of linear equations in the coupled variables <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e370" xlink:type="simple"/></inline-formula>. Solving this linear system we find that the solution can be written as:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e371" xlink:type="simple"/><label>(23)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e372" xlink:type="simple"/><label>(24)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e373" xlink:type="simple"/><label>(25)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e374" xlink:type="simple"/><label>(26)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e375" xlink:type="simple"/></inline-formula> is the activated upstream enzyme when <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e376" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e377" xlink:type="simple"/></inline-formula>. Let us remark that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e378" xlink:type="simple"/></inline-formula> or <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e379" xlink:type="simple"/></inline-formula> means respectively that the upstream cycle is highly activated or strongly deactivated.</p>
        <p>By combining Eqs.(20), (22) and (25), one obtains the characteristic range for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e380" xlink:type="simple"/></inline-formula>, as defined by Eq.(20):<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e381" xlink:type="simple"/><label>(27)</label></disp-formula>In the case where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e382" xlink:type="simple"/></inline-formula>, the upstream cycle is such that there is no phosphatase to deactivate it, so that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e383" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e384" xlink:type="simple"/></inline-formula>. In this case, using the definition <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e385" xlink:type="simple"/></inline-formula>, Eq.(27) becomes the sought relation Eq.(1), i.e.:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e386" xlink:type="simple"/><label>(28)</label></disp-formula>One easily shows that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e387" xlink:type="simple"/></inline-formula> (because <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e388" xlink:type="simple"/></inline-formula>). Therefore <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e389" xlink:type="simple"/></inline-formula> can be used as an upper bound of the characteristic range for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e390" xlink:type="simple"/></inline-formula>. Particularly, if the downstream cycle is strongly activated, then <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e391" xlink:type="simple"/></inline-formula> and then <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e392" xlink:type="simple"/></inline-formula> is an excellent approximation of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e393" xlink:type="simple"/></inline-formula>. On the other hand, if the downstream cycle is strongly deactivated, so that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e394" xlink:type="simple"/></inline-formula>, one can use <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e395" xlink:type="simple"/></inline-formula>, that is the lower value reached by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e396" xlink:type="simple"/></inline-formula> in the limit <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e397" xlink:type="simple"/></inline-formula>.</p>
        <p>Let us note that using the definition of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e398" xlink:type="simple"/></inline-formula> in the simple situation <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e399" xlink:type="simple"/></inline-formula>, the derivatives <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e400" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e401" xlink:type="simple"/></inline-formula> in eqs.(25)–(26) can be written in a compact form, namely:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e402" xlink:type="simple"/><label>(29)</label></disp-formula>Incidently, these expressions give the initial slope of the curves drawn on <xref ref-type="fig" rid="pone-0040806-g002">Figs. 2(D-E)</xref>.</p>
        <p>Now, to justify Eqs.(2)–(3) given in the Results, we wish to compute the asymptotic values of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e403" xlink:type="simple"/></inline-formula> in the limit of large <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e404" xlink:type="simple"/></inline-formula>. As suggested by the numerical computations, we first suppose that the asymptotic behavior of these variables are described by:</p>
        <p> <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e405" xlink:type="simple"/><label>(30)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e406" xlink:type="simple"/><label>(31)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e407" xlink:type="simple"/><label>(32)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e408" xlink:type="simple"/><label>(33)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e409" xlink:type="simple"/></inline-formula> are unknown constants to be worked out. Substitution of these relations in Eqs.(15)–(18) with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e410" xlink:type="simple"/></inline-formula> determines <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e411" xlink:type="simple"/></inline-formula>. Since <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e412" xlink:type="simple"/></inline-formula> must be positive, this case is only consistent with the hypothesis <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e413" xlink:type="simple"/></inline-formula>, that is equivalent to Eq. (2) given in the Result section. Let us notice that here the result is independent on considering the case <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e414" xlink:type="simple"/></inline-formula> or not. The values of the other unknowns are found to be <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e415" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e416" xlink:type="simple"/></inline-formula>, and</p>
        <p><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e417" xlink:type="simple"/><label>(34)</label></disp-formula>Secondly, in order to justify Eq.(3), we suppose another asymptotic behavior for the system variables in the limit of large <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e418" xlink:type="simple"/></inline-formula>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e419" xlink:type="simple"/><label>(35)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e420" xlink:type="simple"/><label>(36)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e421" xlink:type="simple"/><label>(37)</label></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e422" xlink:type="simple"/><label>(38)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e423" xlink:type="simple"/></inline-formula> are new unknown constants to be determined. The calculation can be done in 2 steps. First <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e424" xlink:type="simple"/></inline-formula> can be calculated by solving Eqs.(15)–(16) which here becomes:</p>
        <p><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e425" xlink:type="simple"/></disp-formula><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e426" xlink:type="simple"/></disp-formula>This system can be interpreted as finding the activated and deactivated proteins in the upstream cycle with the reduced amount of total protein <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e427" xlink:type="simple"/></inline-formula>. The latter must be positive, that is equivalent to the condition <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e428" xlink:type="simple"/></inline-formula> related to Eq.(3). The solution of this system is hard to write explicitly, except in the case <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e429" xlink:type="simple"/></inline-formula> where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e430" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e431" xlink:type="simple"/></inline-formula>.</p>
        <p>The second step is to solve Eqs.(17)–(18) in the limit <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e432" xlink:type="simple"/></inline-formula>. Then one easily finds that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e433" xlink:type="simple"/></inline-formula>, and therefore<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e434" xlink:type="simple"/><label>(39)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e435" xlink:type="simple"/></inline-formula> has been found in the first step. The latter equation generalizes Eq. (3), which holds in the case where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e436" xlink:type="simple"/></inline-formula>. Then the simple expression of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e437" xlink:type="simple"/></inline-formula> leads to the equality <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e438" xlink:type="simple"/></inline-formula> which is Eq. (3). Finally the value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e439" xlink:type="simple"/></inline-formula> is the same expression as Eq.(34), but swapping the “primed” and “not primed” parameters.</p>
        <p>In conclusion, by using Eqs.(29)–(38), let us note that we can sketch the behavior of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e440" xlink:type="simple"/></inline-formula> and of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e441" xlink:type="simple"/></inline-formula> as a function of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e442" xlink:type="simple"/></inline-formula> as piecewise linear graphs (see red lines on <xref ref-type="fig" rid="pone-0040806-g002">Figs. 2(D)</xref>–(E)).</p>
      </sec>
      <sec id="s4c">
        <title>Variation of the Downstream Phosphatase in a 2-cycle Cascade</title>
        <p>Let us consider a 2-cycle cascade as drawn on <xref ref-type="fig" rid="pone-0040806-g001">Fig. 1(A)</xref> and suppose now that the control parameter is the quantity of phosphatase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e443" xlink:type="simple"/></inline-formula> in the downstream cycle 1. We wish to prove the result of Eq.(5) giving the phosphorylated fraction <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e444" xlink:type="simple"/></inline-formula> of protein in cycle 2 in the limit of large <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e445" xlink:type="simple"/></inline-formula>.</p>
        <p>First recall that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e446" xlink:type="simple"/></inline-formula> is defined by the chemical compounds containing <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e447" xlink:type="simple"/></inline-formula>, namely (cf. Eq.(4)):<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e448" xlink:type="simple"/></disp-formula>Thus, by using the steady expression for the complexes <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e449" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e450" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e451" xlink:type="simple"/></inline-formula> is also expressed as:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e452" xlink:type="simple"/><label>(40)</label></disp-formula>We wish to remove the dependency in <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e453" xlink:type="simple"/></inline-formula> of this expression. The steady state equations of cycle 1 can be written as follows:</p>
        <p>
          <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e454" xlink:type="simple"/><label>(41)</label></disp-formula>
          <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e455" xlink:type="simple"/></disp-formula>
        </p>
        <p>Since <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e456" xlink:type="simple"/></inline-formula> is an enzyme, in the limit <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e457" xlink:type="simple"/></inline-formula>, none of the biochemical variables should diverge. Therefore the second equation in the above system implies that in this limit one has <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e458" xlink:type="simple"/></inline-formula>. Thus the Eq.(41) can be simplified into the form:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e459" xlink:type="simple"/><label>(42)</label></disp-formula>This enables to write <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0040806.e460" xlink:type="simple"/></inline-formula> as:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e461" xlink:type="simple"/><label>(43)</label></disp-formula>And by using this expression in Eq.(40), one finds Eq.(5), or: <disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0040806.e462" xlink:type="simple"/><label>(44)</label></disp-formula></p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pone.0040806-Nelson1">
        <label>1</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>D</given-names></name><name name-style="western"><surname>Cox</surname><given-names>M</given-names></name></person-group>             <year>2004</year>             <article-title>Lehninger Principles of Biochemistry, Fourth Edition.</article-title>             <source>W. H. Freeman, 1100 pp</source>          </element-citation>
      </ref>
      <ref id="pone.0040806-Seger1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Seger</surname><given-names>R</given-names></name><name name-style="western"><surname>Krebs</surname><given-names>EG</given-names></name></person-group>             <year>1995</year>             <article-title>The mapk signaling cascade.</article-title>             <source>FASEB J</source>             <volume>9</volume>             <fpage>726</fpage>             <lpage>35</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Huang1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Ferrell</surname><given-names>JE</given-names></name></person-group>             <year>1996</year>             <article-title>Ultrasensitivity in the mitogen-activated protein kinase cascade.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>93</volume>             <fpage>10078</fpage>             <lpage>83</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Elion1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Elion</surname><given-names>EA</given-names></name><name name-style="western"><surname>Qi</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name></person-group>             <year>2005</year>             <article-title>Signal transduction. signaling specificity in yeast.</article-title>             <source>Science</source>             <volume>307</volume>             <fpage>687</fpage>             <lpage>8</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Goldbeter1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Goldbeter</surname><given-names>A</given-names></name><name name-style="western"><surname>Koshland JD</surname><given-names>E</given-names></name></person-group>             <year>1981</year>             <article-title>An amplified sensitivity arising from covalent modification in biological systems.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>78</volume>             <fpage>6840</fpage>             <lpage>4</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Qiao1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Qiao</surname><given-names>L</given-names></name><name name-style="western"><surname>Nachbar</surname><given-names>RB</given-names></name><name name-style="western"><surname>Kevrekidis</surname><given-names>IG</given-names></name><name name-style="western"><surname>Shvartsman</surname><given-names>SY</given-names></name></person-group>             <year>2007</year>             <article-title>Bistability and oscillations in the huang-ferrell model of mapk signaling.</article-title>             <source>PLoS Comput Biol</source>             <volume>3</volume>             <fpage>1819</fpage>             <lpage>26</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Feliu1">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Feliu</surname><given-names>E</given-names></name><name name-style="western"><surname>Knusden</surname><given-names>M</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>L</given-names></name><name name-style="western"><surname>Wiuf</surname><given-names>C</given-names></name></person-group>             <year>2012</year>             <article-title>An algebraic approach to signaling cascades with n layers.</article-title>             <source>Bull Math Biol</source>             <volume>74</volume>             <fpage>45</fpage>             <lpage>72</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Ventura1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ventura</surname><given-names>AC</given-names></name><name name-style="western"><surname>Sepulchre</surname><given-names>JA</given-names></name><name name-style="western"><surname>Merajver</surname><given-names>SD</given-names></name></person-group>             <year>2008</year>             <article-title>A hidden feedback in signaling cascades is revealed.</article-title>             <source>PLoS Comput Biol</source>             <volume>4</volume>             <fpage>e1000041</fpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-DelVecchio1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Del Vecchio</surname><given-names>D</given-names></name><name name-style="western"><surname>Ninfa</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Sontag</surname><given-names>ED</given-names></name></person-group>             <year>2008</year>             <article-title>Modular cell biology: retroactivity and insulation.</article-title>             <source>Mol Syst Biol</source>             <volume>4</volume>             <fpage>161</fpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Ossareh1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ossareh</surname><given-names>HR</given-names></name><name name-style="western"><surname>Ventura</surname><given-names>AC</given-names></name><name name-style="western"><surname>Merajver</surname><given-names>SD</given-names></name><name name-style="western"><surname>Del Vecchio</surname><given-names>D</given-names></name></person-group>             <year>2011</year>             <article-title>Long signaling cascades tend to attenuate retroactivity.</article-title>             <source>Biophys J</source>             <volume>100</volume>             <fpage>1617</fpage>             <lpage>26</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Andrianantoandro1">
        <label>11</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Andrianantoandro</surname><given-names>E</given-names></name><name name-style="western"><surname>Basu</surname><given-names>S</given-names></name><name name-style="western"><surname>Karig</surname><given-names>DK</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>R</given-names></name></person-group>             <year>2006</year>             <article-title>Synthetic biology: new engineering rules for an emerging discipline.</article-title>             <source>Mol Syst Biol 2: 2006 0028</source>          </element-citation>
      </ref>
      <ref id="pone.0040806-Franco1">
        <label>12</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Franco</surname><given-names>E</given-names></name><name name-style="western"><surname>Del Vecchio</surname><given-names>D</given-names></name><name name-style="western"><surname>Murray</surname><given-names>R</given-names></name></person-group>             <year>2009</year>             <article-title>Design of insulating devices for in vitro synthetic circuits.</article-title>             <source>In: Proceedings of the IEEE Conference on Decision and Control, Shangai.</source>             <fpage>4584</fpage>             <lpage>4589</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Anderson1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>J</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Papachristodoulou</surname><given-names>A</given-names></name></person-group>             <year>2011</year>             <article-title>Model decomposition and reduction tools for large-scale networks in systems biology.</article-title>             <source>Automatica</source>             <volume>47</volume>             <fpage>1165</fpage>             <lpage>1174</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Hartwell1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hartwell</surname><given-names>LH</given-names></name><name name-style="western"><surname>Hopfield</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Leibler</surname><given-names>S</given-names></name><name name-style="western"><surname>Murray</surname><given-names>AW</given-names></name></person-group>             <year>1999</year>             <article-title>From molecular to modular cell biology.</article-title>             <source>Nature</source>             <volume>402</volume>             <fpage>C47</fpage>             <lpage>52</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Alexander1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>RP</given-names></name><name name-style="western"><surname>Kim</surname><given-names>PM</given-names></name><name name-style="western"><surname>Emonet</surname><given-names>T</given-names></name><name name-style="western"><surname>Gerstein</surname><given-names>MB</given-names></name></person-group>             <year>2009</year>             <article-title>Understanding modularity in molecular networks requires dynamics.</article-title>             <source>Sci Signal</source>             <volume>2</volume>             <fpage>pe44</fpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Wynn1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wynn</surname><given-names>M</given-names></name><name name-style="western"><surname>Ventura</surname><given-names>A</given-names></name><name name-style="western"><surname>Sepulchre</surname><given-names>JA</given-names></name><name name-style="western"><surname>Garca</surname><given-names>H</given-names></name><name name-style="western"><surname>Merajver</surname><given-names>S</given-names></name></person-group>             <year>2011</year>             <article-title>Kinase inhibitors can produce off-target effects and activate linked pathways by retroactivity.</article-title>             <source>BMC Systems Biology</source>             <volume>5</volume>             <fpage>156</fpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Kim1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Paroush</surname><given-names>Z</given-names></name><name name-style="western"><surname>Nairz</surname><given-names>K</given-names></name><name name-style="western"><surname>Hafen</surname><given-names>E</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>G</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Substrate-dependent control of mapk phosphorylation in vivo.</article-title>             <source>Mol Syst Biol</source>             <volume>7</volume>             <fpage>467</fpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Ventura2">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ventura</surname><given-names>AC</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>P</given-names></name><name name-style="western"><surname>Van Wassenhove</surname><given-names>L</given-names></name><name name-style="western"><surname>Del Vecchio</surname><given-names>D</given-names></name><name name-style="western"><surname>Merajver</surname><given-names>SD</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Signaling properties of a covalent modification cycle are altered by a downstream target.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>107</volume>             <fpage>10032</fpage>             <lpage>7</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Kim2">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Coppey</surname><given-names>M</given-names></name><name name-style="western"><surname>Grossman</surname><given-names>R</given-names></name><name name-style="western"><surname>Ajuria</surname><given-names>L</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>G</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Mapk substrate competition integrates patterning signals in the drosophila embryo.</article-title>             <source>Curr Biol</source>             <volume>20</volume>             <fpage>446</fpage>             <lpage>51</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Goldbeter2">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Goldbeter</surname><given-names>A</given-names></name></person-group>             <year>1991</year>             <article-title>A minimal cascade model for the mitotic oscillator involving cyclin and cdc2 kinase.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>88</volume>             <fpage>9107</fpage>             <lpage>11</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Callis1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Callis</surname><given-names>J</given-names></name><name name-style="western"><surname>Vierstra</surname><given-names>RD</given-names></name></person-group>             <year>2000</year>             <article-title>Protein degradation in signaling.</article-title>             <source>Curr Opin Plant Biol</source>             <volume>3</volume>             <fpage>381</fpage>             <lpage>6</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Soyer1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Soyer</surname><given-names>OS</given-names></name><name name-style="western"><surname>Kuwahara</surname><given-names>H</given-names></name><name name-style="western"><surname>Csikasz-Nagy</surname><given-names>A</given-names></name></person-group>             <year>2009</year>             <article-title>Regulating the total level of a signaling protein can vary its dynamics in a range from switch like ultrasensitivity to adaptive responses.</article-title>             <source>FEBS J</source>             <volume>276</volume>             <fpage>3290</fpage>             <lpage>8</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Kumar1">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>N</given-names></name><name name-style="western"><surname>Afeyan</surname><given-names>R</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HD</given-names></name><name name-style="western"><surname>Lauffenburger</surname><given-names>DA</given-names></name></person-group>             <year>2008</year>             <article-title>Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of her2-overexpressing mammary epithelial cells.</article-title>             <source>Mol Pharmacol</source>             <volume>73</volume>             <fpage>1668</fpage>             <lpage>78</lpage>          </element-citation>
      </ref>
      <ref id="pone.0040806-Jiang1">
        <label>24</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>P</given-names></name><name name-style="western"><surname>Ventura</surname><given-names>AC</given-names></name><name name-style="western"><surname>Sontag</surname><given-names>ED</given-names></name><name name-style="western"><surname>Merajver</surname><given-names>SD</given-names></name><name name-style="western"><surname>Ninfa</surname><given-names>AJ</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Load-induced modulation of signal transduction networks.</article-title>             <source>Sci Signal 4</source>          </element-citation>
      </ref>
      <ref id="pone.0040806-Zumsande1">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zumsande</surname><given-names>M</given-names></name><name name-style="western"><surname>Gross</surname><given-names>T</given-names></name></person-group>             <year>2010</year>             <article-title>Bifurcations and chaos in the mapk signaling cascade.</article-title>             <source>J of Theor Biol</source>             <volume>265</volume>             <fpage>481</fpage>             <lpage>491</lpage>          </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>